Nombre del producto |
N-{4-[2-(2-amino-4-oxo-1,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl}-L-glutamic acid |
Nombre en inglés |
N-{4-[2-(2-amino-4-oxo-1,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl}-L-glutamic acid; (R)-N-(4-(2-(2-Amino-1,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl)ethyl)benzoyl)-L-glutamic Acid; L-Glutamic acid, N-(4-(2-(2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl)ethyl)benzoyl)-, (R)-; L-glutamic acid, N-[4-[2-(2-amino-5,6,7,8-tetrahydro-4-hydroxypyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl]-; N-{4-[2-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl}-L-glutamic acid; 5,10-Dideazatetrahydrofolic Acid |
Fórmula molecular |
C21H25N5O6 |
Peso Molecular |
443.4531 |
InChI |
InChI=1/C21H25N5O6/c22-21-25-17-14(19(30)26-21)9-12(10-23-17)2-1-11-3-5-13(6-4-11)18(29)24-15(20(31)32)7-8-16(27)28/h3-6,12,15H,1-2,7-10H2,(H,24,29)(H,27,28)(H,31,32)(H4,22,23,25,26,30)/t12?,15-/m0/s1 |
Número de registro CAS |
116387-29-2;95693-76-8 |
Estructura Molecular |
|
Densidad |
1.56g/cm3 |
Índice de refracción |
1.709 |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|